Skip to content
Alfasigma
-
Alfasigma expands specialty care portfolio with Nordic Group acquisition
The transaction will be completed through a share purchase agreement with SEVER Life Sciences, under which Alfasigma will acquire 100% of Nordic Group and its subsidiaries.